 Daily Mail | NHS patients may be denied new prostate cancer drug Best Medical Cover The National Institute for Health and Clinical Excellence (NICE) says that abiraterone in combination with prednisone or prednisolone is not recommended for men with prostate cancer that has spread following chemotherapy and cannot be operated upon. Zytiga cost too high, says NICE NICE draft "no" for Zytiga Charities condemn 'no' decision on prostate drug |
